NAUT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome...

Stats
Today's Volume	27 717.00
Average Volume	77 580.00
Market Cap	311.49M
EPS	$0 ( 2024-02-28 )
Next earnings date	( $0 ) 2024-05-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.88
ATR14	$0.0190 (0.76%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-11	Patel Sujal M	Buy	12 044	Common Stock
2024-03-08	Patel Sujal M	Buy	2 430	Common Stock
2024-03-07	Patel Sujal M	Buy	18 854	Common Stock
2024-03-06	Patel Sujal M	Buy	9 267	Common Stock
2024-03-05	Patel Sujal M	Buy	7 405	Common Stock

INSIDER POWER
95.66
Last 97 transactions
Buy: 21 218 105 \| Sell: 5 493 083

Volume Correlation

Long: 0.26 (neutral)

Short: 0.51 (weak)

Signal:(55.686) Neutral

Nautilus Biotechnology, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Nautilus Biotechnology, Correlation - Currency/Commodity

0.01
( neutral )

0.02
( neutral )

0.00
( neutral )

-0.34
( neutral )

0.00
( neutral )

0.18
( neutral )

Nautilus Biotechnology, Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-5.71M (0.00 %)
EPS:	$-0.510

FY	2023
Revenue:	$0
Gross Profit:	$-5.71M (0.00 %)
EPS:	$-0.510

FY	2022
Revenue:	$0
Gross Profit:	$-3.42M (0.00 %)
EPS:	$-0.510

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.405

Financial Reports:

No articles found.

Nautilus Biotechnology,

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.

Realtime updates for Nautilus Biotechnology, [NAUT]

Upcoming Earnings Alert